References

[1] McFadden, E. (1998) Chapter 5: Data Entry and Distributed Computing, in Management of Data in Clinical Trials, pp. 73-87. John Wiley, New York.

[2] Gibson, D., Harvey, A.J., Everett, V., and Parmar, M.K.B. on behalf of the CHART Steering Committee (1994). Is double data entry necessary? The CHART trials. Controlled Clinical Trials, 15, 482-8.

[3] Earlam, R. (1991) An MRC prospective randomized trial of radiotherapy versus surgery for operable squamous cell carcinoma of the oesophagus. Annals of the Royal College of Surgeons of England, 73, 8-12.

[4] Medical Research Council Lung Cancer Working Party (1999) Treatment of endotracheal and endobronchial obstruction by non-small cell lung cancer: lack of patients in an MRC randomized trial leaves key questions unanswered. Clinical Oncology, 11, 179-83.

[5] Medical Research Council (1997) MRC Policy and Procedure for Inquiring into Allegations of Scientific Misconduct. Medical Research Council, London.

[6] Ranstam, J., Buyse, M., George, S.L., Evans, S., Geller, N.L., Scherrer, B., Lesaffre, E., Murray, G., Edler, L., Hutton, J.L., Colton, T., and Lachenbruch P. for the ISCB Subcommittee on Fraud (2000) Fraud in medical research: an international survey of biostatisticians. Controlled Clinical Trials, 21, 415-27.

[7] Smith, R. (1996) Time to face up to research misconduct. British Medical Journal, 312, 789-90.

[8] Rennie, D., Evans, I., Farthing, M.J.G., Chantler, C., Chantler, S., Riis, P., Poloniecki, J., Irving, M., Berwick, D.M., Rubin, P., Treasure, T., and Klein, R. (1998) Dealing with research misconduct in the United Kingdom. British Medical Journal, 316, 1726-42.

[9] Evered, D., and Lazar, P. (1995) Misconduct in medical research. Lancet, 345, 1161-2.

[10] Evans, I. (1998) Dealing with research misconduct in the United Kingdom: conduct unbecoming -the MRC's approach. British Medical Journal, 316, 1728-9.

[11] Buyse, M., George, S.L., Evans, S., Geller, N.L., Ranstam, J., Scherrer, B., Lesaffre, E., Murray, G., Edler, L., Hutton, J., Colton, T., Lachenbruch, P., and Verma, B.L. for the ISCB Subcommittee on Fraud (1999) The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Statistics in Medicine, 18, 3435-51.

[12] Martyn, C. (1996) Not quite as random as I pretended. Lancet, 347, 70.

[13] Atterstam, I. (1997) Karolinska Institute rocked by research misconduct. Lancet, 350, 643.

[14] White, C. (1998) Call for research misconduct agency. British Medical Journal, 316, 1695.

0 0

Post a comment